-
Journal of Experimental Pharmacology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Cytoprotective effect of Semecarpus anacardium against toxicity induced by Streptozotocin in rats
Original Research
(1443) Views (762) Full article downloads
Authors: Jaya Aseervatham, Shanthi Palanivelu, Panchanadham Sachdanandam
Published Date August 2010
Volume 2010:2 Pages 135 - 143
DOI: http://dx.doi.org/10.2147/JEP.S11466
Jaya Aseervatham1, Shanthi Palanivelu2, Panchanadham Sachdanandam1
1Department of Medical Biochemistry, 2Department of Pathology, Dr ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, India
Abstract: Leakage of cellular enzymes into the plasma is a clear indication of cell damage. When liver plasma membrane is damaged, a variety of enzymes normally located in the cytosol are released into the blood stream and their estimation is a quantitative marker for the extent of damage. The cytoprotective effect of Semecarpus anacardium was evaluated in rats that were rendered diabetic by administration of streptozotocin at a dose of 50 mg/kg body weight. The activities of the marker enzymes were assayed in the serum, liver and kidney. The indicators of renal damage such as urea, uric acid and creatinine were assayed in addition to the blood profile. The results of the present study reveal that Semecarpus anacardium was able to reverse the levels of the marker enzymes, and protect the kidney by reverting back to the normal levels of urea, uric acid, and creatinine. The abnormal blood parameters were also reverted to near normal levels indicating the drug’s cytoprotective effect.
Keywords: marker enzymes, Semecarpus anacardium, blood profile, cytoprotective effect
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Tenofovir-associated bone density loss
- The benefits and risks of testosterone replacement therapy: a review
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




